These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28745824)

  • 1. Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis.
    Ma D; Wang J; Hao X; Wang Y; Hu X; Xing P; Li J
    Thorac Cancer; 2017 Sep; 8(5):482-488. PubMed ID: 28745824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
    Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
    Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
    Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
    J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer.
    Yamaguchi M; Takeo S; Suemitsu R; Matsuzawa H
    Cancer Chemother Pharmacol; 2010 May; 66(1):107-12. PubMed ID: 19809815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer.
    Funai K; Takamochi K; Itaya T; Mochizuki T; Nakamura T; Toyoda F; Yong-Il K; Sasaki K; Momiki S; Takahashi T; Neyatani H; Suzuki K
    Lung Cancer; 2010 Apr; 68(1):78-83. PubMed ID: 19570590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
    Kontopodis E; Kotsakis A; Kentepozidis N; Syrigos K; Ziras N; Moutsos M; Filippa G; Mala A; Vamvakas L; Mavroudis D; Georgoulias V; Agelaki S
    Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
    Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
    J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
    Cappuzzo F; Selvaggi G; Gregorc V; Mazzoni F; Betti M; Rita Migliorino M; Novello S; Maestri A; De Marinis F; Darwish S; De Angelis V; Nelli F; Bartolini S; Scagliotti GV; Tonato M; Crinò L
    Cancer; 2003 Jul; 98(1):128-34. PubMed ID: 12833465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
    Scagliotti GV
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.
    Aydiner A; Kiyik M; Cikrikcioglu S; Kosar F; Gurses A; Turna A; Yazar A; Dilege S; Goksel T; Cakan A
    Lung Cancer; 2007 Nov; 58(2):246-52. PubMed ID: 17683827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.
    Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A
    Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
    Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
    J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer.
    Davidov MI; Polotzky BE; Marenich AF; Orlov SV; Lazarev AF; Skryabina LS; Pavlushkov EV; Semenchenya VA; Brichkova OY; Karaseva VV
    Anticancer Drugs; 2011 Jul; 22(6):569-75. PubMed ID: 21487288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
    Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
    Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.
    Rossi D; Graziano F; Catalano V; Giordani P; Fedeli SL; Alessandroni P; Fedeli A; Dennetta D; Ugolini M; Catalano G
    Anticancer Res; 2002; 22(5):3087-92. PubMed ID: 12530048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
    Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
    Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
    Huisman C; Giaccone G; van Groeningen CJ; Sutedja G; Postmus PE; Smit EF
    Lung Cancer; 2001; 33(2-3):267-75. PubMed ID: 11551422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
    Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
    World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.